(Q36624004)

15 August 2017

Darbepoetin alfa given every 1 or 2 weeks alleviates anaemia associated with cancer chemotherapy (English)

1 reference

15 August 2017

0 references

1 reference

J A Glaspy

1

1 reference

15 August 2017

J S Jadeja

2

1 reference

15 August 2017

G Justice

3

1 reference

15 August 2017

J Kessler

4

1 reference

15 August 2017

D Richards

5

1 reference

15 August 2017

L Schwartzberg

6

1 reference

15 August 2017

N S Tchekmedyian

7

1 reference

15 August 2017

S Armstrong

8

1 reference

15 August 2017

J O'Byrne

9

1 reference

15 August 2017

G Rossi

10

1 reference

15 August 2017

A B Colowick

11

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 July 2002

1 reference

British Journal of Cancer

15 August 2017

1 reference

15 August 2017

87

1 reference

15 August 2017

3

1 reference

15 August 2017

268-276

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6600465

15 August 2017

0 references

cites work

An overview of the efficacy and safety of novel erythropoiesis stimulating protein (NESP).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364226

Novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia of chronic disease associated with cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364226

A dose-finding and safety study of novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia in patients receiving multicycle chemotherapy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364226

Pharmacokinetics of novel erythropoiesis stimulating protein (NESP) in cancer patients: preliminary report

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364226

Development and characterization of novel erythropoiesis stimulating protein (NESP)

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364226

Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364226

Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364226

Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364226

Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: improvements in hemoglobin and quality of life are similar to three-times-weekly dosing.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364226

Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. Procrit Study Group.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364226

Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue Coalition

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364226

Pharmacokinetics of novel erythropoiesis stimulating protein compared with epoetin alfa in dialysis patients

20 September 2018

1 reference

12 December 2020

Decreased erythropoietin response in patients with the anemia of cancer

1 reference

12 December 2020

Recombinant human erythropoietin treatment in cisplatin-associated anemia: a randomized, double-blind trial with placebo

1 reference

12 December 2020

Recombinant human erythropoietin in the treatment of cancer and chemotherapy-induced anemia: results of double-blind and open-label follow-up studies

1 reference

12 December 2020

Identifiers

DOI

10.1038/SJ.BJC.6600465

1 reference

release_ru4a73j7xbc6lebrhw4mbop2yi

15 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ru4a73j7xbc6lebrhw4mbop2yi

24 November 2022

mapped directly with Wikidata item

1 reference

15 August 2017

1 reference